Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

GLORY launches the GLR Series of next generation Teller Cash Recyclers
GLORY launches the GLR Series of next generation Teller Cash Recyclers


Today, Glory announces the latest solution in its new GLR series of Teller Cash Recyclers (TCRs) the GLR-200. Building upon the successful launch of GLR-100 in August this year, the new Roll

GLORY launches the GLR Series of next generation Teller Cash Recyclers
GLORY launches the GLR Series of next generation Teller Cash Recyclers


Today, Glory announces the latest solution in its new GLR series of Teller Cash Recyclers (TCRs) the GLR-200. Building upon the successful launch of GLR-100 in August this year, the new Roll

EQS-News: Medios AG presents growth strategy and announces medium-term targets at Capital Markets Day 2022
EQS-News: Medios AG presents growth strategy and announces medium-term targets at Capital Markets Day 2022
EQS-News: Medios AG presents growth strategy and announces medium-term targets at Capital Markets Day 2022
Major Bulk Order (33rd Term Contract) for 300 Elevators Received From the Housing & Development Board of Singapore (HDB)
Major Bulk Order (33rd Term Contract) for 300 Elevators Received From the Housing & Development Board of Singapore (HDB)


Fujitec Singapore Corpn. Ltd. (Head Office: Bedok South Avenue, Singapore; Managing Director William Wong), a group subsidiary of FUJITEC CO., LTD. (Head Office: Shiga Prefecture, Japan; President

CI Global Asset Management Launches CI Global Investment Grade Fund
CI Global Asset Management Launches CI Global Investment Grade Fund


CI Global Asset Management (“CI GAM”) today launched CI Global Investment Grade Fund (“the Fund”), a new option for investors seeking regular income and the expertise of an award-winning investment

EQS-Adhoc: Medios AG: Acquisition of Blisterzentrum Baden-Württemberg GmbH and expansions in the area of sterile manufacturing
EQS-Adhoc: Medios AG: Acquisition of Blisterzentrum Baden-Württemberg GmbH and expansions in the area of sterile manufacturing
EQS-Adhoc: Medios AG: Acquisition of Blisterzentrum Baden-Württemberg GmbH and expansions in the area of sterile manufacturing
Lysogene Provides Updates and Topline Results from Phase 2/3 AAVance Gene Therapy Clinical Study
Lysogene Provides Updates and Topline Results from Phase 2/3 AAVance Gene Therapy Clinical Study


Regulatory News:



Lysogene (FR0013233475 – LYS) (Paris:LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, today announced topline results from the Phase

Lysogene to Provide Updates and Topline Results from Phase 2/3 AAVance Gene Therapy Clinical Study and Host Webcast on Wednesday, November 23, 2022
Lysogene to Provide Updates and Topline Results from Phase 2/3 AAVance Gene Therapy Clinical Study and Host Webcast on Wednesday, November 23, 2022


Regulatory News:



Lysogene (FR0013233475 – LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, today announced that it will host a live webcast on

Granite REIT Declares Distribution for November 2022
Granite REIT Declares Distribution for November 2022


Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2583 per stapled unit for the month of

CI Global Asset Management Mutual Funds and ETFs Recognized for Investment Excellence
CI Global Asset Management Mutual Funds and ETFs Recognized for Investment Excellence


CI Global Asset Management (“CI GAM”) announced today that its investment funds have been recognized with 14 Refinitiv Canada Lipper Fund Awards for 2022. The awards recognize mutual funds and

Vistagen Announces Publication in Cells Demonstrating AV-101’s Potential for Treating Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease
Vistagen Announces Publication in Cells Demonstrating AV-101’s Potential for Treating Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease


Vistagen (NASDAQ: VTGN) a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system

CI Global Asset Management Announces November 2022 Distributions for CI ETFs
CI Global Asset Management Announces November 2022 Distributions for CI ETFs


CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending November 30, 2022 in respect of the CI ETFs. In all cases, the distribution will be

CI Financial Reports Total Assets of $364.3 Billion for October 2022
CI Financial Reports Total Assets of $364.3 Billion for October 2022


CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today reported preliminary total assets of $364.3 billion as at October 31, 2022, consisting of asset management assets of $116.3 billion, Canadian

Mannatech Declares Third Quarter 2022 Dividend
Mannatech Declares Third Quarter 2022 Dividend


Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend

Vistagen Reports Second Quarter Financial Results and Provides Corporate Update
Vistagen Reports Second Quarter Financial Results and Provides Corporate Update


Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system

CI Financial Reports Financial Results for the Third Quarter of 2022
CI Financial Reports Financial Results for the Third Quarter of 2022


CI Financial Corp. (“CI”) (TSX: CIX, NYSE: CIXX) today released financial results for the quarter ended September 30, 2022.



“CI continues to produce exceptional results in the face of difficult

EQS-News: Medios AG continues growth course in the first nine months of 2022 – guidance for the 2022 financial year confirmed
EQS-News: Medios AG continues growth course in the first nine months of 2022 – guidance for the 2022 financial year confirmed
EQS-News: Medios AG continues growth course in the first nine months of 2022 – guidance for the 2022 financial year confirmed
Granite Announces 2022 Third Quarter Results and a 3.2% Distribution Increase Commencing December 2022
Granite Announces 2022 Third Quarter Results and a 3.2% Distribution Increase Commencing December 2022


Granite Real Estate Investment Trust and Granite REIT Inc. (TSX: GRT.UN; NYSE: GRP.U) (“Granite” or the “Trust”) announced today its combined results for the three and nine month periods ended

Fuel Tech Reports 2022 Third Quarter Financial Results
Fuel Tech Reports 2022 Third Quarter Financial Results


Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control, and water treatment in utility and

Mannatech Reports Third Quarter End 2022 Financial Results
Mannatech Reports Third Quarter End 2022 Financial Results


Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2022.

Mannatech is Reinventing Hydration, Introduces Exclusive Blue Water
Mannatech is Reinventing Hydration, Introduces Exclusive Blue Water


Global health and wellness brand Mannatech, Incorporated (NASDAQ: MTEX) announces its latest innovation today with the launch of Blue Water, a functional drink for both hydration and immune

Vistagen to Report Fiscal Year 2023 Second Quarter Financial Results on November 10, 2022
Vistagen to Report Fiscal Year 2023 Second Quarter Financial Results on November 10, 2022


Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system

Fuel Tech Awarded Air Pollution Control Orders Totaling $2.7 Million
Fuel Tech Awarded Air Pollution Control Orders Totaling $2.7 Million


Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and

Vistagen to Present at Stifel 2022 Healthcare Conference
Vistagen to Present at Stifel 2022 Healthcare Conference


Vistagen Therapeutics, Inc. (Nasdaq: VTGN) (Vistagen, the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety

Fuel Tech Schedules 2022 Third Quarter Financial Results and Conference Call
Fuel Tech Schedules 2022 Third Quarter Financial Results and Conference Call


Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control and water treatment in utility and